Literature DB >> 2660697

Human endothelial cells produce IL-6. Lack of responses to exogenous IL-6.

T J Podor1, F R Jirik, D J Loskutoff, D A Carson, M Lotz.   

Abstract

The interaction between human endothelial cells and leukocytes during immunological and inflammatory responses is in part mediated through the release of soluble mediators. We report that cultured human umbilical vein endothelial cells secrete IL-6 when stimulated with lipopolysaccharide. The monokines, IL-1 and TNF-alpha, were potent inducers of IL-6, whereas lymphotoxin was only effective at much higher concentrations. IFN gamma also was a strong stimulus of IL-6 production, but TGF-beta did not have an effect at doses modulating other endothelial cell functions. Endothelial cell IL-6 was active as hybridoma-plasmacytoma growth factor and as B-cell and hepatocyte stimulating factor. Endothelial IL-6 activity was neutralized by a specific antibody to IL-6 and it was shown by immunoprecipitation to be identical in size to human fibroblast-derived IL-6. IL-6 did not have a detectable effect on several endothelial cell functions, including proliferation, adherence of leukocytes, and synthesis of PGE2, TPA, and PAI-1. As IL-6 is probably an important regulator of host defense responses, production of this cytokine by endothelial cells may contribute to the pathogenesis of various inflammatory and immunologic diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660697

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.

Authors:  S A Miles; A R Rezai; J F Salazar-González; M Vander Meyden; R H Stevens; D M Logan; R T Mitsuyasu; T Taga; T Hirano; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.

Authors:  G Tosato; J Tanner; K D Jones; M Revel; S E Pike
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.

Authors:  V A Danis; G M Franic; D A Rathjen; R M Laurent; P M Brooks
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

4.  Ciliary neurotrophic factor is an endogenous pyrogen.

Authors:  L Shapiro; X X Zhang; R G Rupp; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

5.  Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

Authors:  Brooke Ancrile; Kian-Huat Lim; Christopher M Counter
Journal:  Genes Dev       Date:  2007-07-15       Impact factor: 11.361

6.  Genome-wide association study of circulating interleukin 6 levels identifies novel loci.

Authors:  Tarunveer S Ahluwalia; Bram P Prins; Mohammadreza Abdollahi; Nicola J Armstrong; Stella Aslibekyan; Lisa Bain; Barbara Jefferis; Jens Baumert; Marian Beekman; Yoav Ben-Shlomo; Joshua C Bis; Braxton D Mitchell; Eco de Geus; Graciela E Delgado; Diana Marek; Joel Eriksson; Eero Kajantie; Stavroula Kanoni; John P Kemp; Chen Lu; Riccardo E Marioni; Stela McLachlan; Yuri Milaneschi; Ilja M Nolte; Alexandros M Petrelis; Eleonora Porcu; Maria Sabater-Lleal; Elnaz Naderi; Ilkka Seppälä; Tina Shah; Gaurav Singhal; Marie Standl; Alexander Teumer; Anbupalam Thalamuthu; Elisabeth Thiering; Stella Trompet; Christie M Ballantyne; Emelia J Benjamin; Juan P Casas; Catherine Toben; George Dedoussis; Joris Deelen; Peter Durda; Jorgen Engmann; Mary F Feitosa; Harald Grallert; Ann Hammarstedt; Sarah E Harris; Georg Homuth; Jouke-Jan Hottenga; Sirpa Jalkanen; Yalda Jamshidi; Magdalene C Jawahar; Tine Jess; Mika Kivimaki; Marcus E Kleber; Jari Lahti; Yongmei Liu; Pedro Marques-Vidal; Dan Mellström; Simon P Mooijaart; Martina Müller-Nurasyid; Brenda Penninx; Joana A Revez; Peter Rossing; Katri Räikkönen; Naveed Sattar; Hubert Scharnagl; Bengt Sennblad; Angela Silveira; Beate St Pourcain; Nicholas J Timpson; Julian Trollor; Jenny van Dongen; Diana Van Heemst; Sophie Visvikis-Siest; Peter Vollenweider; Uwe Völker; Melanie Waldenberger; Gonneke Willemsen; Delilah Zabaneh; Richard W Morris; Donna K Arnett; Bernhard T Baune; Dorret I Boomsma; Yen-Pei C Chang; Ian J Deary; Panos Deloukas; Johan G Eriksson; David M Evans; Manuel A Ferreira; Tom Gaunt; Vilmundur Gudnason; Anders Hamsten; Joachim Heinrich; Aroon Hingorani; Steve E Humphries; J Wouter Jukema; Wolfgang Koenig; Meena Kumari; Zoltan Kutalik; Deborah A Lawlor; Terho Lehtimäki; Winfried März; Karen A Mather; Silvia Naitza; Matthias Nauck; Claes Ohlsson; Jackie F Price; Olli Raitakari; Ken Rice; Perminder S Sachdev; Eline Slagboom; Thorkild I A Sørensen; Tim Spector; David Stacey; Maria G Stathopoulou; Toshiko Tanaka; S Goya Wannamethee; Peter Whincup; Jerome I Rotter; Abbas Dehghan; Eric Boerwinkle; Bruce M Psaty; Harold Snieder; Behrooz Z Alizadeh
Journal:  Hum Mol Genet       Date:  2021-04-27       Impact factor: 6.150

7.  IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules.

Authors:  Shanzhou Duan; Ying Tsai; Peter Keng; Yongbing Chen; Soo Ok Lee; Yuhchyau Chen
Journal:  Oncotarget       Date:  2015-09-29

8.  Activation of C6 glioblastoma cell ceruloplasmin expression by neighboring human brain endothelia-derived interleukins in an in vitro blood-brain barrier model system.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Cell Commun Signal       Date:  2014-10-14       Impact factor: 5.712

Review 9.  Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature.

Authors:  Sean P Didion
Journal:  Int J Mol Sci       Date:  2017-11-29       Impact factor: 5.923

Review 10.  Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Front Mol Neurosci       Date:  2015-07-14       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.